Editorial: Inflammatory bowel disease, irritable bowel syndrome, or what: A challenge to the functional-organic dichotomy

American Journal of Gastroenterology

Volumn 105, Issue 8, 2010, Pages 1796-1798

  Long, Millie D ^a,b   Drossman, Douglas A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN; BIOLOGICAL MARKER; CYTOKINE;

CROHN DISEASE; DIARRHEA; DISEASE ACTIVITY; ENTERITIS; FECES LEVEL; HUMAN; INFLAMMATION; IRRITABLE COLON; PRIORITY JOURNAL; REMISSION; REVIEW; STRESS; ULCERATIVE COLITIS; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; FECES; MENTAL STRESS; NOTE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK FACTOR;

BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; FECES; HUMANS; IRRITABLE BOWEL SYNDROME; LEUKOCYTE L1 ANTIGEN COMPLEX; QUALITY OF LIFE; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 77955365656     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.162     Document Type: Review

References (20)

1. Grover M, Herfarth H, Drossman DA. The functional-organicdichotomy: postinfectious irritable bowel syndrome and inflammatorybowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol2009; 7: 48-53.
2. Keohane J, O'Mahony C, O'Mahony L. Irritable bowel syndrometypesymptoms in patients with inflammatory bowel disease: a realassociation or reflection of occult inflammation? Am J Gastroenterol2010;105:1789-1794 (this issue).
3. Minderhoud IM, Oldenburg B, Wismeijer JA et al. IBS-like symptoms inpatients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004; 49: 469-474
4. Drossman DA. P residential address: gastrointestinal illness and the biopsychosocialmodel. Psychosom Med 1998; 60: 258-267
5. Dinan TG, Quigley EM, Ahmed SM et al. Hypothalamic-pituitary-gut axisdysregulation in irritable bowel syndrome: plasma cytokines as a potentialbiomarker? Gastroenterology 2006; 130: 304-311
6. O' Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacteriumin irritable bowel syndrome: symptom responses and relationship tocytokine profiles. Gastroenterology 2005; 128: 541-551
7. Macsharry J, O'Mahony L, Fanning A et al. Mucosal cytokine imbalance inirritable bowel syndrome. Scand J Gastroenterol 2008; 43: 1467-1476
8. Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells inproximity to colonic nerves correlate with abdominal pain in irritablebowel syndrome. Gastroenterology 2004; 126: 693-702.
9. Barbara G, Wang B, Stanghellini V et al. Mast cell-dependent excitation ofvisceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007; 132: 26-37.
10. Drossman DA, Ringel Y. Psychosocial factors in ulcerative colitis andCrohn's disease. In: Sartor RB (ed). Kirsner's Inflammatory Bowel Disease,6Thedn. W.B. Saunders: London, 2004, pp. 340-356
11. Sperber AD, Morris CB, Greemberg L et al. Development of abdominalpain and IBS following gynecological surgery: a prospective, controlledstudy. Gastroenterology 2008; 134: 75-84.
12. Drossman DA, Whitehead WE, Toner BB et al. What determines severityamong patients with painful functional bowel disorders? Am J Gastroenterol2000; 95: 974-980
13. Creed F, Levy R, Bradley L et al. Psychosocial aspects of functionalgastrointestinal disorders. In: Drossman DA, Corazziari E, Delvaux M,Spiller RC, Talley NJ, Th ompson WG (eds). Rome III: The FunctionalGastrointestinal Disorders, 3rd edn. Degnon Associates Inc: McLean, VA,2006, pp. 295-368.
14. Levenstein S, Prantera C, Varvo V et al. Stress and exacerbation in ulcerativecolitis: a prospective study of patients enrolled in remission. Am JGastroenterol 2000; 95: 1213-1220
15. Soderholm JD, Perdue MH. Effect of stress on intestinal mucosal functions.In: Johnson L (ed). Physiology of the Gastrointestinal Tract. Elsevier AcademicPress: Burlington, San Diego and London, 2006. pp. 763-780
16. LutgendorffF, Akkermans LM, Soderholm JD. The role of microbiota and probioticsin stress-induced gastro-intestinal damage. Curr Mol Med 2008; 8: 282-298
17. Drossman DA. Brain imaging and its implications for studying centrallytargeted treatments in irritable bowel syndrome: a primer for gastroenterologists. Gut 2005; 54: 569-573
18. Drossman DA, Ringel Y, Vogt BA et al. Alterations of brain activityassociated with resolution of emotional distress and pain in a case of severeirritable bowel syndrome. Gastroenterology 2003; 124: 754-761
19. Ringel Y, Drossman DA, Leserman JL et al. Effect of abuse history on painreports and brain responses to aversive visceral stimulation: an FMRI study.Gastroenterology 2008; 134: 396-404.
20. Drossman DA. Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms. Am J Gastroenterol2009; 104: 2897-2902